Department of General Surgery, University of Health Sciences Turkey, Gaziosmanpasa Training and Research Hospital, Istanbul, Turkey
Department of Pathology, University of Health Sciences Turkey, Gaziosmanpasa Training and Research Hospital, Istanbul, Turkey.
Anticancer Res. 2020 Oct;40(10):5649-5657. doi: 10.21873/anticanres.14578.
In recent years, GATA-binding protein 3 (GATA3) has been indicated as a marker showing good prognosis in breast cancer. In luminal breast cancer, which has good a prognosis, it shows more significant elevation in small-sized and low-grade tumors. In contrast, Ki-67 is defined as a poor prognostic factor. The aim of this study was to emphasise the prognostic importance of GATA3 and the inverse relationship with Ki-67.
In our study, 90 patients with invasive ductal breast cancer were immunohistochemically evaluated for Ki-67 and GATA3 expression. The relationship between GATA3 and Ki-67 expression was examined. In addition, the relationship between these two factors with estrogen, progesterone, human epidermal growth factor 2 receptor antibodies and other prognostic parameters such as disease-free survival and local recurrence was investigated. We accepted the level of ≥5% nüclear reaction as positive for GATA 3. A Ki-67 cut-off value of 20% was accepted as positive.
In GATA3 positive breast cancers, good prognostic parameters were seen including high estrogen receptor (ER) positivity, progesterone receptor (PR) positivity, small tumor size and low histological grade as well as low Ki-67 expression. In breast cancers showing high Ki-67 expression, ER, PR, and GATA3 positivity were lower and there was higher human epidermal growth factor receptor 2 (HER2) positivity and high histological grade while the tumor size was larger.
Our study has revealed that GATA3 has an inverse relationship with Ki-67, whereas it has a positive releationship with good prognostic factors.
近年来,GATA 结合蛋白 3(GATA3)已被证明是乳腺癌预后良好的标志物。在预后良好的 luminal 型乳腺癌中,它在小肿瘤和低级别肿瘤中表现出更为显著的升高。相比之下,Ki-67 被定义为预后不良的因素。本研究旨在强调 GATA3 的预后重要性及其与 Ki-67 的反向关系。
在我们的研究中,对 90 例浸润性导管乳腺癌患者进行了 Ki-67 和 GATA3 表达的免疫组织化学评估。检查了 GATA3 与 Ki-67 表达之间的关系。此外,还研究了这两个因素与雌激素、孕激素、人表皮生长因子 2 受体抗体以及无病生存和局部复发等其他预后参数之间的关系。我们将≥5%核反应水平视为 GATA3 阳性。接受 Ki-67 阳性的截断值为 20%。
在 GATA3 阳性的乳腺癌中,观察到良好的预后参数,包括高雌激素受体(ER)阳性、孕激素受体(PR)阳性、肿瘤体积小、组织学分级低以及 Ki-67 表达低。在 Ki-67 表达较高的乳腺癌中,ER、PR 和 GATA3 阳性率较低,HER2 阳性率较高,组织学分级较高,肿瘤体积较大。
我们的研究表明,GATA3 与 Ki-67 呈负相关,而与良好的预后因素呈正相关。